The ICALIC International Multicentric Study
ICALIC
Clinical Evaluation of the Ease of Use of a New Indirect Calorimeter for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study
1 other identifier
observational
272
6 countries
7
Brief Summary
This study will evaluate the ease of use of the new calorimeter (Q-NRG (COSMED, Italy)) in intensive care unit (ICU) patients compared to currently used calorimeters (i.e. Quark RMR 1.0(COSMED, Italy) or Deltatrac Metabolic Monitor (Datex, Finland)), as well as the stability and the feasibility of the measurements in various clinically relevant situations. Time needed to prepare and start indirect calorimetry (IC) measurement will be compared as the measure of the ease of use of the calorimeter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2017
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2016
CompletedFirst Posted
Study publicly available on registry
June 10, 2016
CompletedStudy Start
First participant enrolled
September 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2019
CompletedJuly 22, 2019
July 1, 2019
1.9 years
May 31, 2016
July 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time needed to start indirect calorimetry (IC) measurement in Q-NRG compared to currently used calorimeters
Time from the start-up of the devices until the 1st recorded measurement will be measured and compared between Q-NRG and the currently used indirect calorimeters, including time needed for patient information input, warm-up and calibrations according to the instructions for the devices, and installation of the device components needed for the measurements on patients.
immediately after the measurement
Secondary Outcomes (6)
Comparison of energy expenditure(EE) from Q-NRG and currently used calorimeters
immediately after the measurement
Coefficient of variation (CV) of EE for different mechanical ventilators
immediately after the measurement
CV of EE when using different ventilation modes
immediately after the measurement
CV of EE in various ranges of oxygen and airway pressure support
immediately after the measurement
CV of EE when measured in different sedation/consciousness levels
immediately after the measurement
- +1 more secondary outcomes
Study Arms (1)
Mechanically ventilated patients
Ease of use will be assessed by analysing the time needed to start indirect calorimetry measurement, and results of indirect calorimetry measurements by both the new indirect calorimeter and the currently used calorimeters at each study center.
Interventions
Comparison of the time needed to start EE measurements by the new calorimeter and the currently used calorimeter, including the time needed for calibration, patient data input, connection to the ventilator circuit.
Comparison of EE measurements by the new calorimeter and the currently used calorimeter when using different mechanical ventilators, different ventilation modes, different patient conditions and severity
Eligibility Criteria
Mechanically ventilated adult ICU patients
You may qualify if:
- Mechanically ventilated adult ICU patients
You may not qualify if:
- Fraction of inhaled oxygen (FIO2) \> 70%
- Positive end expiratory pressure (PEEP) \>10cmH2O
- Peak ventilatory pressure \> 30cmH2O
- Presence of air leaks from thoracic drain tube
- Changes in vasoactive agent dose (\>20%, \<1 hr before and/or during IC)
- Agitation or change in sedative dose (\>20%, \<1 hr before and/or during IC)
- Change in body temperature (\>0.5°C, \<1 hr before and/or during IC)
- Expected duration of ICU stay \< 24 hours
- Expected survival of the patient \< 24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine
Vienna, Austria
Department of Intensive Care, Vrije Universiteit Brussel
Brussels, Belgium
Critical Care Medicine, Institute for Nutrition Research, Rabin Medical Center, Beilison Hospital
Petah Tikva, 49100, Israel
Chiba University Hospital
Chiba, Japan
Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital
Huddinge, Sweden
Service of Intensive Care, Geneva University Hospital
Geneva, 1211, Switzerland
Adult Intensive care, Lausanne University Hospital
Lausanne, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claude Pichard, MD, PhD
Clinical Nutrition, Geneva University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Claude Pichard, MD, PhD
Study Record Dates
First Submitted
May 31, 2016
First Posted
June 10, 2016
Study Start
September 10, 2017
Primary Completion
July 19, 2019
Study Completion
July 19, 2019
Last Updated
July 22, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share